Burundi vs Switzerland: Access to anti-retroviral drugs, male
Burundi
90.0%
in 2024
Switzerland
90.0%
in 2023
Burundi rank
13th
Switzerland rank
13th
Access to anti-retroviral drugs, male over time
- Burundi
- Switzerland
How they compare
Burundi currently reports 90.0% against 90.0% in Switzerland, a difference of 0.0%.
Across all 24 years both countries report, Switzerland has been ahead every year.
Burundi ranks 13th and Switzerland ranks 13th of 141 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burundi | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.8% | 50.0% | 43.2% | Switzerland |
| 2010s | 45.6% | 79.2% | 33.6% | Switzerland |
| 2020s | 84.2% | 90.2% | 6.0% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Burundi or Switzerland?
- Burundi, at 90.0% against 90.0% in Switzerland as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Burundi and Switzerland?
- 0.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Switzerland?
- 24 years are reported by both, from 2000 to 2023.
- How do Burundi and Switzerland rank globally for access to anti-retroviral drugs, male?
- Burundi ranks 13th and Switzerland ranks 13th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.